Recombinant Activated Factor VII as a Second Line Treatment for Postpartum Hemorrhage.
Soon Chang ParkSeok-Ran YeomSang Kyoon HanYoung Mo JoHyung Bin KimPublished in: Korean journal of critical care medicine (2017)
This analysis aimed to support that the administration of rFVIIa can reduce the severity of life-threatening PPH in patients. A rapid decision regarding the administration of rFVIIa is needed for a more favorable outcome in severe PPH patients for whom there is no effective standard treatment.